Association between aspirin use and risk of hepatocellular carcinoma
TG Simon, Y Ma, JF Ludvigsson, DQ Chong… - JAMA …, 2018 - jamanetwork.com
Importance Prospective data on the risk of hepatocellular carcinoma (HCC) according to
dose and duration of aspirin therapy are limited. Objective To examine the potential benefits
of aspirin use for primary HCC prevention at a range of doses and durations of use within 2
prospective, nationwide populations. Design, Setting, and Participants Pooled analysis of 2
prospective US cohort studies: the Nurses' Health Study and the Health Professionals
Follow-up Study. Data were accessed from November 1, 2017, through March 7, 2018. A …
dose and duration of aspirin therapy are limited. Objective To examine the potential benefits
of aspirin use for primary HCC prevention at a range of doses and durations of use within 2
prospective, nationwide populations. Design, Setting, and Participants Pooled analysis of 2
prospective US cohort studies: the Nurses' Health Study and the Health Professionals
Follow-up Study. Data were accessed from November 1, 2017, through March 7, 2018. A …
